Company
Fresenius Medical Care
Last checked: Nov 21, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
58
510(k), De Novo and PMA
Device trials
28
As lead sponsor, any status
Adverse event reports
75
Received Nov 1, 2025 to Nov 21, 2026
Recall records
209
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
FMS
NYSE · Fresenius Medical Care AG
Public float
Unknown
Not reported in US filings
Revenue
Not reported
Net income
Not reported
R&D spending
Not reported
Cash
Not reported
Long-term debt
Not reported
Shares outstanding
279.3M
As of Dec 31, 2025
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.
The investor database is free with an account
Sign up free with your name, company and ZIP code to see the 5%+ shareholders and government grant funders behind device companies.
Latest FDA decisions
The 8 newest of 58 since 2015.
- multiFiltratePRO System510(k)
K261203 · Decided Oct 19, 2026 · 189 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
57 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Analysis of TPE Treatments With multiFiltratePROActive, not recruiting
NCT06272084 · 60 participants (planned) · Start May 22, 2024 · Primary completion Feb 22, 2026
Device: Therapeutic Plasma Exchange (TPE) option of multiFiltratePRO · For: Autoimmune Diseases
Sites: Aschaffenburg, Germany; Würzburg, Germany; Berlin, Germany
27 more trials with a free account
Reports received
75
Received Nov 1, 2025 to Nov 21, 2026
Malfunction reports
69
92% of reports
Injury reports
5
6.7% of reports
Death reports
1
1.3% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 1 | 0 | 0 |
| Jan 24 | 0 | 0 | 2 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 1 | 0 |
| Jun 24 | 1 | 1 | 0 | 0 |
| Jul 24 | 0 | 2 | 0 | 0 |
| Aug 24 | 4 | 0 | 0 | 0 |
| Sep 24 | 2 | 3 | 1 | 0 |
| Oct 24 | 2 | 1 | 0 | 0 |
| Nov 24 | 2 | 3 | 0 | 0 |
| Dec 24 | 4 | 0 | 0 | 0 |
| Jan 25 | 0 | 6 | 1 | 0 |
| Feb 25 | 1 | 0 | 0 | 1 |
| Mar 25 | 0 | 5 | 0 | 0 |
| Apr 25 | 1 | 0 | 1 | 0 |
| May 25 | 2 | 2 | 0 | 0 |
| Jun 25 | 2 | 0 | 0 | 0 |
| Jul 25 | 8 | 0 | 0 | 0 |
| Aug 25 | 6 | 0 | 0 | 1 |
| Sep 25 | 2 | 5 | 0 | 0 |
| Oct 25 | 1 | 0 | 0 | 0 |
| Nov 25 | 1 | 1 | 0 | 0 |
| Dec 25 | 2 | 3 | 0 | 0 |
| Jan 26 | 2 | 1 | 0 | 0 |
| Feb 26 | 9 | 0 | 0 | 0 |
| Mar 26 | 37 | 0 | 0 | 0 |
| Apr 26 | 4 | 0 | 0 | 0 |
| May 26 | 3 | 0 | 0 | 0 |
| Jun 26 | 6 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 1 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 3 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
3 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-3084-2026 · Started Aug 10, 2026 · Posted by FDA Sep 2, 2026
Reason given: Heightened probability of blood leak from the connection between the Arterial Alpha Clip and the main line or pump segment. Leak during treatment may lead to blood loss and hypovolemia.
Cause as FDA categorized it: Component change control · Device type: Accessories, Blood Circuit, Hemodialysis (KOC)
208 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.